B-Lymphocyte Antigen CD20 (MS4A1) Antibody (APC)
377€ (50 tests)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
B-Lymphocyte Antigen CD20 (MS4A1) Antibody (APC)
category
Primary Antibodies
provider
Abbexa
reference
abx240336
tested applications
FCM
Description
B-Lymphocyte Antigen CD20 (MS4A1) Antibody (APC) is a Mouse Monoclonal antibody conjugated to APC for the detection of Human B-Lymphocyte Antigen CD20 (MS4A1).
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | B-Lymphocyte Antigen CD20 (MS4A1) |
| Host | Mouse |
| Reactivity | Human |
| Recommended Dilution | FCM: 5 µl/106 cells in 100 µl volume, or 100 µl whole blood. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Monoclonal |
| Conjugation | APC |
| Isotype | IgG2a Kappa |
| Size 1 | 50 tests |
| Size 2 | 100 tests |
| Form | Liquid |
| Tested Applications | FCM |
| Buffer | PBS, pH 7.3, containing 0.1% sodium azide and 1% BSA. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store between 2-8 °C. |
| Dry Ice | No |
| UniProt ID | P11836 |
| Gene ID | 931 |
| Alias | B1,S7,Bp35,CD20,FMC7,CVID5,LEU-16,B-lymphocyte antigen CD20,B-lymphocyte surface antigen B1,Leukocyte surface antigen Leu-16,Membrane-spanning 4-domains subfamily A member 1 |
| Background | Antibody anti-MS4A1 |
| Status | RUO |
| Note | - Validity: 12 months. |
Descripción
Related Products
Human MS4A1(B-lymphocyte antigen CD20) ELISA Kit
Ver Producto
Mouse CD20 (B-lymphocyte antigen CD20) ELISA Kit
Ver Producto
anti- CD20 antibody
CD20 is a 33-37 kDa transmembrane phosphoprotein. CD20 is a B-lymphocyte surface molecule that is widely expressed during B-cell ontogeny, from early pre-B-cell developmental stages until final differentiation into plasma cells. CD20 functions as calcium-permeable cation channel. It is involved in the regulation of B-cell activation and proliferation. CD20 serves as a useful target for antibody-mediated therapeutic depletion of B-cells.
Ver Producto